Bleakley Financial Group’s Elevance Health ELV Stock Holding History

Bleakley Financial Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,856	Closed	-$1.42M	–	648
2024 Q4	$1.42M	Sell	3,856 -1,961	-34%	-$821K	0.04%	323
2024 Q3	$3.02M	Sell	5,817 -18,556	-76%	-$9.91M	0.09%	184
2024 Q2	$13.2M	Buy	24,373 +65	+0.3%	+$34.4K	0.38%	48
2024 Q1	$12.6M	Buy	24,308 +19,850	+445%	+$9.87M	0.36%	50
2023 Q4	$2.1M	Buy	4,458 +262	+6%	+$121K	0.07%	269
2023 Q3	$1.83M	Sell	4,196 -174	-4%	-$78.9K	0.06%	280
2023 Q2	$1.94M	Sell	4,370 -5	-0.1%	-$2.31K	0.06%	280
2023 Q1	$2.01M	Sell	4,375 -316	-7%	-$150K	0.07%	252
2022 Q4	$2.41M	Buy	+4,691	New	+$2.38M	0.09%	213

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Bleakley Financial Group's ELV Position: Q1 2025 in Review

Bleakley Financial Group sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 3,856 shares — an estimated $1.42M sold.

Bleakley Financial Group first reported a position in ELV in Q4 2022 and held it in 9 quarters. The position peaked at $13.2M in Q2 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

Bleakley Financial Group reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
Bleakley Financial Group sold 3,856 Elevance Health shares in Q1 2025, an estimated $1.42M.
Bleakley Financial Group first reported a position in Elevance Health in Q4 2022 and held it in 9 quarters.
Bleakley Financial Group's Elevance Health position peaked at $13.2M in Q2 2024.
1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.